154 related articles for article (PubMed ID: 32559765)
1. Factor XII and kininogen asymmetric assembly with gC1qR/C1QBP/P32 is governed by allostery.
Kaira BG; Slater A; McCrae KR; Dreveny I; Sumya U; Mutch NJ; Searle M; Emsley J
Blood; 2020 Oct; 136(14):1685-1697. PubMed ID: 32559765
[TBL] [Abstract][Full Text] [Related]
2. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.
Mahdi F; Madar ZS; Figueroa CD; Schmaier AH
Blood; 2002 May; 99(10):3585-96. PubMed ID: 11986212
[TBL] [Abstract][Full Text] [Related]
3. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
[TBL] [Abstract][Full Text] [Related]
4. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
[TBL] [Abstract][Full Text] [Related]
6. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.
Ghebrehiwet B; CebadaMora C; Tantral L; Jesty J; Peerschke EI
Adv Exp Med Biol; 2006; 586():95-105. PubMed ID: 16893067
[TBL] [Abstract][Full Text] [Related]
7. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
[TBL] [Abstract][Full Text] [Related]
8. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
[TBL] [Abstract][Full Text] [Related]
9. gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII.
Zhang Y; Vontz AJ; Kallenberger EM; Xu X; Ploscariu NT; Ramyar KX; Garcia BL; Ghebrehiwet B; Geisbrecht BV
Front Immunol; 2022; 13():887742. PubMed ID: 35865516
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
11. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
[TBL] [Abstract][Full Text] [Related]
12. Interaction of high molecular weight kininogen binding proteins on endothelial cells.
Joseph K; Tholanikunnel BG; Ghebrehiwet B; Kaplan AP
Thromb Haemost; 2004 Jan; 91(1):61-70. PubMed ID: 14691569
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
Joseph K; Ghebrehiwet B; Kaplan AP
Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
Nakazawa Y; Joseph K; Kaplan AP
Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
[TBL] [Abstract][Full Text] [Related]
15. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
16. Binding of activation of kinin-forming proteins on vascular endothelial cells.
Kaplan AP; Joseph K; Shibayama Y
Immunopharmacology; 1997 Jun; 36(2-3):201-7. PubMed ID: 9228547
[No Abstract] [Full Text] [Related]
17. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
Fernando LP; Natesan S; Joseph K; Kaplan AP
Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
[TBL] [Abstract][Full Text] [Related]
18. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
Joseph K; Tholanikunnel BG; Kaplan AP
Int Immunopharmacol; 2002 Dec; 2(13-14):1851-9. PubMed ID: 12489799
[TBL] [Abstract][Full Text] [Related]
19. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
[TBL] [Abstract][Full Text] [Related]
20. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
